Optiray (ioversol) should not be administered to patients with known or suspected hypersensitivity to ioversol or in cases of clinically significant impairment of both hepatic and renal function.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
